Repurposing Drugs for Synergistic Combination Therapies to Counteract Monkeypox Virus Tecovirimat Resistance

Repurposing Drugs for Synergistic Combination Therapies to Counteract Monkeypox Virus Tecovirimat Resistance

The ongoing monkeypox (mpox) disease outbreak has spread to multiple countries in Central Africa and evidence indicates it is driven by a more virulent clade I monkeypox virus (MPXV) strain than the clade II strain associated with the 2022 global mpox outbreak, which led the WHO to declare this mpox...

Full description

Saved in:

Bibliographic Details
Main Authors:	Haydar Witwit, Beatrice Cubitt, Roaa Khafaji, Esteban M. Castro, Miguel Goicoechea, Maria M. Lorenzo, Rafael Blasco, Luis Martinez-Sobrido, Juan C. de la Torre
Format:	Article
Language:	English
Published:	MDPI AG 2025-01-01
Series:	Viruses
Subjects:	monkeypox antiviral mpox drug synergistic interactions <i>Poxviridae</i> VACV
Online Access:	https://www.mdpi.com/1999-4915/17/1/92
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Growing Mpox Infections by Clade I Variant in African Countries Is a Public Health Emergency of International Concern: A Narrative Review
by: Taslima Jamal Urmi, et al.
Published: (2025-01-01)

Tecovirimat in the management of poxviruses: a narrative review of available evidence
by: Olalekan John Okesanya, et al.
Published: (2025-02-01)

A novel isothermal whole genome sequencing approach for Monkeypox Virus
by: Matthias Licheri, et al.
Published: (2024-09-01)

A functional approach to analyze the genetic basis for differences in virulence of monkeypox virus clades
by: Patricia L. Earl, et al.
Published: (2025-12-01)

Systematic review: characteristics of myocarditis followed by fixed drug eruption and dry eye syndrome in patients who have been vaccinated with monkeypox in children and adults
by: R. Mohamad Javier, et al.
Published: (2025-01-01)

Environmental, socioeconomic, and sociocultural drivers of monkeypox transmission in the Democratic Republic of the Congo: a One Health perspective
by: Guangyu Lu, et al.
Published: (2025-02-01)

Flunarizine as a Candidate for Drug Repurposing Against Human Pathogenic Mammarenaviruses
by: Chukwudi A. Ofodile, et al.
Published: (2025-01-01)

Syphilis and Monkeypox: An Issue in Sexual Medicine
by: Rujittika MuUNGMUNPUNTIPANTIP, et al.
Published: (2022-09-01)

Association of HIV infection and hospitalization among mpox cases: a systematic review and meta-analysis
by: Muhammed Shabil, et al.
Published: (2025-01-01)

Monkeypox and other orthopoxvirus zoonoses
by: K. N. Gruzdev
Published: (2022-09-01)

“If that would have lessened my symptoms, that would have been great...”: a qualitative study about the acceptability of tecovirimat as treatment for mpox
by: Sara Paparini, et al.
Published: (2025-01-01)

Characteristics of the monkeypox virus isolate obtained from the first patient in Russia and its sensitivity to 7-[N-(4-trifluoromethylbenzoyl)-hydrazinocarbonyl]-tricyclo-[3.2.2.0^2,4]non-8-en-6-carboxylic acid
by: Alena S. Ovchinnikova, et al.
Published: (2024-12-01)

Comprehensive Insights into Monkeypox (mpox): Recent Advances in Epidemiology, Diagnostic Approaches and Therapeutic Strategies
by: Suresh Kumar, et al.
Published: (2024-12-01)

Attention to Monkeypox: An Interpretable Monkeypox Detection Technique Using Attention Mechanism
by: Avi Deb Raha, et al.
Published: (2024-01-01)

Knowledge, attitude, and perception of Pakistani populations toward monkeypox: a cross-section study
by: Humayun Yousaf, et al.
Published: (2025-02-01)

Novel drug targets for monkeypox: From viral to host proteins
by: Zhaozhong Zhu, et al.
Published: (2025-03-01)

An optimized ensemble grey wolf-based pipeline for monkeypox diagnosis
by: Ahmed I. Saleh, et al.
Published: (2025-01-01)

Monkeypox: a re-emergent virus with global health implications – a comprehensive review
by: Nourhan G. Naga, et al.
Published: (2025-01-01)

Penerapan Blok SE-NET Pada Deep Learning Inceptionv3 untuk Meningkatkan Deteksi Penyakit Mpox pada Manusia
by: M. Bakhara Alief Rachman, et al.
Published: (2024-10-01)

Sculpting multi-epitope vaccine against Monkeypox viral strains using immunoinformatics
by: Zaira Rehman, et al.
Published: (2025-01-01)

Antiviral Activity of the Marine Haptophyta <i>Diacronema lutheri</i>
by: Eleonora Montuori, et al.
Published: (2024-12-01)

Enhancing Monkeypox Detection through Data Analytics: A Comparative Study of Machine and Deep Learning Techniques
by: Kinjal A. Patel, et al.
Published: (2023-12-01)

DeepGenMon: A Novel Framework for Monkeypox Classification Integrating Lightweight Attention-Based Deep Learning and a Genetic Algorithm
by: Abdulqader M. Almars
Published: (2025-01-01)

Preparation and application evaluation of monoclonal antibodies against Monkeypox virus A29 protein
by: Ai Xiangjun, et al.
Published: (2025-01-01)

Mpox in sports: A comprehensive framework for anticipatory planning and risk mitigation in football based on lessons from COVID-19
by: Karim Chamari, et al.
Published: (2024-10-01)

Enhanced Immunogenicity and Affinity with A35R-Fc-Based Chimeric Protein Compared to MPXV A35R Protein
by: Shimeng Bai, et al.
Published: (2025-01-01)

Possible scenarios for the spread of mpox outside the endemic focus in Africa
by: Eskild Petersen, et al.
Published: (2025-04-01)

Dynamic analysis and optimal control of a hybrid fractional monkeypox disease model in terms of external factors
by: Saima Rashid, et al.
Published: (2025-01-01)

Decitabine Increases the Transcription of <i>RIG-I</i> Gene to Suppress the Replication of Feline Calicivirus and Canine Influenza Virus
by: Shaotang Ye, et al.
Published: (2025-01-01)

RIOK1/2 Negatively Regulates the Antiviral Response by Targeting TBK1 in Yellow Catfish (<i>Pelteobagrus fulvidraco</i>)
by: Kejun Liu, et al.
Published: (2024-12-01)

Phytochemical and Metabolomic Investigation of a Popular Traditional Plant from La Réunion: <i>Psiloxylon mauritianum</i>
by: Théo Ozga, et al.
Published: (2025-01-01)

Emergence of Mpox and new epidemics: psychological and social impact of stigma in communication and prevention
by: Giacomo Fiacco, et al.
Published: (2025-01-01)

The Role of Extracts of Edible Parts and Production Wastes of Globe Artichoke (<i>Cynara cardunculus</i> L. var. <i>scolymus</i> (L.)) in Counteracting Oxidative Stress
by: Valentina Laghezza Masci, et al.
Published: (2025-01-01)

Assessment of Knowledge, Attitude, and Associated Factors of Mpox Among Healthcare Professionals at Debre Tabor Comprehensive Specialized Hospital, Northwest Ethiopia, 2024: A Cross‐Sectional Study
by: Teklehaimanot Kiros, et al.
Published: (2025-01-01)

Assessment of MPOX infection-related knowledge levels, concerns, and associated factors: a community-based cross-sectional study
by: Mehmet Emin Arayici, et al.
Published: (2025-01-01)

HDAC6 Facilitates PRV and VSV Infection by Inhibiting Type I Interferon Production
by: Hu Zheng, et al.
Published: (2025-01-01)

Knowledge of Mpox, Media Exposure, and Clinical Experience:
by: Aime Fidele Ndayiragije Mvuyekure, et al.
Published: (2024-12-01)

eEF-2K Deficiency Boosts the Virus-Specific Effector CD8<sup>+</sup> T Cell Responses During Viral Infection
by: Liqing Wang, et al.
Published: (2024-12-01)

Optimizing Microneutralization and IFN-γ ELISPOT Assays to Evaluate Mpox Immunity
by: Yinyi Yu, et al.
Published: (2024-12-01)

Reactogenicity and Immunogenicity Against MPXV of the Intradermal Administration of Modified Vaccinia Ankara Compared to the Standard Subcutaneous Route
by: Valentina Mazzotta, et al.
Published: (2024-12-01)